ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 175 filers reported holding ANTARES PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $86,000 | +7.5% | 21,035 | -6.7% | 0.00% | – |
| Q4 2021 | $80,000 | -5.9% | 22,536 | -3.8% | 0.00% | – |
| Q3 2021 | $85,000 | -14.1% | 23,436 | +2.2% | 0.00% | – |
| Q2 2021 | $99,000 | -4.8% | 22,936 | -9.8% | 0.00% | – |
| Q1 2021 | $104,000 | +1.0% | 25,421 | -1.5% | 0.00% | – |
| Q4 2020 | $103,000 | +47.1% | 25,821 | +0.4% | 0.00% | – |
| Q3 2020 | $70,000 | -2.8% | 25,721 | -1.9% | 0.00% | – |
| Q2 2020 | $72,000 | +35.8% | 26,221 | +17.9% | 0.00% | – |
| Q1 2020 | $53,000 | -42.4% | 22,236 | -18.4% | 0.00% | -100.0% |
| Q3 2019 | $92,000 | +4.5% | 27,236 | +1.9% | 0.00% | 0.0% |
| Q2 2019 | $88,000 | -1.1% | 26,736 | -8.5% | 0.00% | 0.0% |
| Q1 2019 | $89,000 | +9.9% | 29,235 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $81,000 | -16.5% | 29,235 | +1.7% | 0.00% | 0.0% |
| Q3 2018 | $97,000 | +169.4% | 28,735 | +111.3% | 0.00% | – |
| Q2 2018 | $36,000 | +24.1% | 13,600 | 0.0% | 0.00% | – |
| Q1 2018 | $29,000 | +11.5% | 13,600 | 0.0% | 0.00% | – |
| Q4 2017 | $26,000 | -40.9% | 13,600 | +3.8% | 0.00% | – |
| Q3 2017 | $44,000 | +4.8% | 13,100 | +4.0% | 0.00% | – |
| Q2 2017 | $42,000 | +27.3% | 12,600 | +13.5% | 0.00% | – |
| Q1 2017 | $33,000 | +32.0% | 11,100 | 0.0% | 0.00% | – |
| Q4 2016 | $25,000 | +38.9% | 11,100 | 0.0% | 0.00% | – |
| Q3 2016 | $18,000 | +63.6% | 11,100 | -2.6% | 0.00% | – |
| Q2 2016 | $11,000 | +37.5% | 11,400 | 0.0% | 0.00% | – |
| Q1 2016 | $8,000 | -33.3% | 11,400 | 0.0% | 0.00% | – |
| Q4 2015 | $12,000 | -95.6% | 11,400 | -56.8% | 0.00% | -100.0% |
| Q3 2013 | $272,000 | – | 26,410 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|